alexa Stem Cell Transplantation for Treatment of Intractable
ISSN: 2165-7831

Journal of Blood & Lymph
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Stem Cell Transplantation for Treatment of Intractable Diseases

Susumu Ikehara* and Ming Li

Department of Stem Cell Disorders, Kansai Medical University, Hirakata City, Osaka, Japan

*Corresponding Author:
Susumu Ikehara
Department of Stem Cell Disorders
Kansai Medical University
Hirakata City, Osaka 570-1010, Japan
Tel: 81-72-804-2450
Fax: 81-72-804-2454
E-mail: [email protected]

Received Date: September 13, 2013; Accepted Date: November 03, 2013; Published Date: November 05, 2013

Citation: Ikehara S, Li M (2013) Stem Cell Transplantation for Treatment of Intractable Diseases. J Blood Lymph 3:111. doi:10.4172/2165- 7831.1000111

Copyright: © 2013 Ikehara S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Hemopoietic stem cells (HSCs) can be harvested from the bone marrow, peripheral blood or umbilical cord blood. HSC transplantation is used to treat hematologic and lymphoid cancers and other disorders. Some reports have indicated that Bone Marrow Transplantation (BMT) might cure these intractable diseases--including hematological disorders, autoimmune diseases and age-associated diseases. Intra bone marrow- BMT (IBM-BMT) has been proven to be a powerful strategy for allogeneic BMT due to the rapid hemopoietic recovery and the complete restoration of T cell functions. In this review, we summarize the findings of our studies of IBM-BMT to treat some intractable diseases, including cancers such as leukemia, autoimmune diseases such as rheumatoid arthritis and autoimmune pancreatitis, age-related diseases such as osteoporosis and Alzheimer’s disease in mouse models.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords